XML 40 R29.htm IDEA: XBRL DOCUMENT v3.4.0.3
Liability Related to Sale of Future Royalties (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2016
Apr. 30, 2015
Mar. 31, 2015
Mar. 31, 2016
Mar. 31, 2015
Liability Related to Sale of Future Royalties          
Royalty revenue     $ 5,099 $ 195 $ 13,890
Percentage of royalty payments if applicable threshold is met   85.00%      
Immunity Royalty Holdings, L.P          
Liability Related to Sale of Future Royalties          
Percentage of royalty payments   100.00%      
Royalty revenue $ 24,800 $ 235,000      
Royalties on net sales of Kadcyla when royalties to the purchaser reach a specified milestone   $ 260,000      
Percentage of royalty payments if applicable threshold is met   15.00%      
Proceeds from sale of future royalties   $ 200,000      
Transaction costs incurred during royalty purchase agreement   $ 5,900      
Movement in Deferred Revenue [Roll Forward]          
Liability related to sale of future royalties - beginning balance       199,662  
Non cash Kadcyla royalty revenue       (19,355)  
Non cash interest expense recognized       14,330  
Liability related to sale of future royalties - ending balance $ 194,637     $ 194,637  
Effective annual interest rate       9.60%